Results 201 to 210 of about 2,160,662 (298)

Cognitive Behavioral Therapy for Youth with Childhood‐Onset Lupus: A Randomized Clinical Trial

open access: yesArthritis Care &Research, Accepted Article.
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham   +29 more
wiley   +1 more source

Health Care Delivery in Rural Rajasthan [PDF]

open access: yes
Abhijit Banerjee   +2 more
core  

Identifying Patient Preferences for Information About Healthcare AI: A Discrete Choice Experiment

open access: yesMayo Clinic Proceedings: Digital Health
Xuan Zhu, PhD   +7 more
doaj   +1 more source

Immune Checkpoint Inhibitor Related Myositis and Associated Triad Overlap Syndrome

open access: yesArthritis Care &Research, Accepted Article.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino   +9 more
wiley   +1 more source

Effect of Implementing a Dashboard with or without a Best Practice Alert on HLA‐B*58:01 Testing Rates among Allopurinol Users at VA Medical Centers

open access: yesArthritis Care &Research, Accepted Article.
Objective The American College of Rheumatology recommends HLA‐B*58:01 allele testing before the initiation of allopurinol, specifically among Asian and Black/African American patients, due to their increased risk for severe hypersensitivity reactions.
Abimbola Fadairo‐Azinge   +6 more
wiley   +1 more source

Emerging Domains for Measuring Health Care Delivery With Electronic Health Record Metadata.

open access: yesJ Med Internet Res
Tawfik D   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy